SHL highlights the positive effects of the collaboration with PolarCool AB

Report this content

This morning, the Swedish Hockey League (SHL) published results and statistics regarding its active work for player safety. In that work, the collaboration with PolarCool and the use of the PolarCap® System is an important tool, where the effects are now confirmed by SHL itself. The article can be read on SHL.se.

CEO Erik Andersson comments:

"It is satisfying that the collaboration with SHL has had a positive effect for the players and clubs. We want to make a difference mainly for the individual player today and not least in the future. The fact that reduced absence results in financial savings makes the use of PolarCap® System beneficial in that aspect as well.”

SHL's Sports Director Johan Hemlin comments:

“It is very positive that we can state that the introduction of PolarCap® System has resulted in a reduction of the long-term absence among players treated in the acute phase after suffering a concussion. With this treatment we have another tool to use.

For more information

Erik Andersson –  CEO PolarCool AB (publ)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ)

PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.